首页
学术期刊
论文检测
AIGC检测
热点
更多
数据
AntineoplasticsExanthema, rash and lack of efficacy: case report
被引:0
|
作者
:
机构
:
来源
:
Reactions Weekly
|
2022年
/ 1935卷
/ 1期
关键词
:
D O I
:
10.1007/s40278-022-28854-3
中图分类号
:
学科分类号
:
摘要
:
引用
收藏
页码:59 / 59
相关论文
共 50 条
[21]
Multiple drugsVentricular tachycardia, rash and lack of efficacy: case report
Reactions Weekly,
2022,
1929
(1)
: 495
-
495
[22]
Caspofungin/posaconazole/voriconazoleExacerbation of rash and lack of efficacy: case report
Reactions Weekly,
2023,
1941
(1)
: 125
-
125
[23]
Gliclazide/Mesalazine/MetforminItchy rash and lack of efficacy: case report
Reactions Weekly,
2024,
2028
(1)
: 230
-
230
[24]
Ceftriaxone/pneumococcal vaccineDrug rash and lack of efficacy: case report
Reactions Weekly,
2022,
1908
(1)
: 154
-
154
[25]
Multiple drugsPeripheral oedema, rash and lack of efficacy: case report
Reactions Weekly,
2023,
1951
(1)
: 245
-
245
[26]
Multiple drugDysrhythmias, skin rash and lack of efficacy: case report
Reactions Weekly,
2023,
1944
(1)
: 369
-
369
[27]
AntineoplasticsDrug allergy, acneiform rash and lack of efficacy: case report
Reactions Weekly,
2025,
2051
(1)
: 35
-
35
[28]
Anakinra/InfliximabInjection site pain, rash and lack of efficacy: case report
Reactions Weekly,
2024,
2034
(1)
: 32
-
32
[29]
Multiple drugsMyalgias, rigours and acneiform rash and Lack of efficacy: case report
Reactions Weekly,
2022,
1907
(1)
: 346
-
346
[30]
Durvalumab/TremelimumabGrade 3 maculopapular rash and lack of efficacy: case report
Reactions Weekly,
2024,
2031
(1)
: 151
-
151
←
1
2
3
4
5
→